Published in J Virol on April 01, 1996
In vivo monocyte tropism of pathogenic feline immunodeficiency viruses. J Virol (1999) 0.98
Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3. Retrovirology (2004) 0.97
Gamma interferon/interleukin 10 balance in tissue lymphocytes correlates with down modulation of mucosal feline immunodeficiency virus infection. J Virol (2004) 0.91
Immunohistochemical localization of feline immunodeficiency virus using native species antibodies. Am J Pathol (2002) 0.83
Feline immunodeficiency virus latency. Retrovirology (2013) 0.81
Association of plasma viral RNA load with prognosis in cats naturally infected with feline immunodeficiency virus. J Virol (2002) 0.81
Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat. Front Biosci (2007) 0.80
Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase. PLoS One (2016) 0.77
Domain- and nucleotide-specific Rev response element regulation of feline immunodeficiency virus production. Virology (2010) 0.75
Altered Immune Cytokine Expression Associated with KoRV B Infection and Season in Captive Koalas. PLoS One (2016) 0.75
The molecular biology and evolution of feline immunodeficiency viruses of cougars. Vet Immunol Immunopathol (2008) 0.75
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 6.56
Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88
Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet (1985) 4.83
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest (1988) 3.59
A formalin-inactivated whole SIV vaccine confers protection in macaques. Science (1989) 3.37
Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques (1993) 3.36
Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication. J Virol (1995) 2.96
Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol (1990) 2.40
Feline immunodeficiency virus infection in cats of Japan. J Am Vet Med Assoc (1989) 2.13
Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev (1995) 2.06
Monoclonal antibodies to three epitopic regions of feline leukemia virus p27 and their use in enzyme-linked immunosorbent assay of p27. J Immunol Methods (1983) 1.94
Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol (1991) 1.83
Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolates. Virology (1990) 1.79
Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol (1994) 1.59
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci U S A (1993) 1.54
Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis (1994) 1.53
Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS (1993) 1.48
Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci U S A (1994) 1.48
Early events in the immunopathogenesis of feline retrovirus infections. J Am Vet Med Assoc (1991) 1.32
Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J Virol (1995) 1.30
Effect of platelet-associated virus on assays of HIV-1 in plasma. Science (1993) 1.26
Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology (1993) 1.24
Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR. J Virol (1995) 1.23
Vertical transmission of feline immunodeficiency virus. AIDS Res Hum Retroviruses (1995) 1.19
Clinical staging of feline immunodeficiency virus infection. Nihon Juigaku Zasshi (1990) 1.18
Serological responses of cats to feline immunodeficiency virus. AIDS (1990) 1.14
Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats. AIDS (1989) 1.13
Hematologic manifestations of feline immunodeficiency virus infection. Blood (1990) 1.10
Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology. Virology (1991) 1.01
High levels of circulating RNA in patients with symptomatic HIV-1 infection. AIDS (1993) 0.91
HIV-1 infection in the lymphoid organs. AIDS (1993) 0.90
Biochemical and immunological characterization of the major structural proteins of feline immunodeficiency virus. J Gen Virol (1990) 0.89
Evolving understanding of the immunopathogenesis of HIV. AIDS Res Hum Retroviruses (1994) 0.87
The effect of age on the course of experimental feline immunodeficiency virus infection in cats. AIDS Res Hum Retroviruses (1993) 0.86
Interleukin-2 suppression in cats naturally infected with feline leukemia virus. J Biol Response Mod (1989) 0.82
Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science (1988) 2.86
Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol (1988) 2.62
Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. Nature (1986) 2.52
Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J Gen Virol (1999) 2.48
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
Transduction of endogenous envelope genes by feline leukaemia virus in vitro. Nature (1988) 1.94
Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J Virol (1986) 1.84
Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol (1991) 1.83
Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol (1994) 1.59
Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immune Defic Syndr (1990) 1.59
Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Res (1979) 1.56
Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades. J Virol (1997) 1.55
Identification of a CD4 homologue in the cat. Tissue Antigens (1990) 1.51
Experimentally induced feline chlamydial infection (feline pneumonitis). Am J Vet Res (1978) 1.48
Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus. J Virol (1989) 1.48
Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proc Natl Acad Sci U S A (1988) 1.45
PrP(CWD) in the myenteric plexus, vagosympathetic trunk and endocrine glands of deer with chronic wasting disease. J Gen Virol (2001) 1.45
Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein. Nature (1978) 1.39
Pathogenesis of experimental feline leukemia virus infection. J Natl Cancer Inst (1979) 1.33
Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J Virol (1995) 1.28
Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. J Virol (1996) 1.23
Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR. J Virol (1995) 1.23
Vertical transmission of feline immunodeficiency virus. AIDS Res Hum Retroviruses (1995) 1.19
Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1998) 1.19
Immunologic reactivity of the cat: immunosuppression in experimental feline leukemia. J Natl Cancer Inst (1972) 1.19
Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein. Proc Natl Acad Sci U S A (1992) 1.18
Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol (1990) 1.18
Erythroid hypoplasia in cats inoculated with feline leukemia virus. J Natl Cancer Inst (1974) 1.16
Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors. J Virol (1994) 1.16
Early pathogenesis of disease caused by SIVsmmPBj14 molecular clone 1.9 in macaques. AIDS Res Hum Retroviruses (1993) 1.14
Feline immunodeficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells. Vet Immunol Immunopathol (1992) 1.14
Growth of lion and puma lentiviruses in domestic cat cells and comparisons with FIV. Virology (1997) 1.07
Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus. AIDS Res Hum Retroviruses (1997) 1.06
Experimentally induced feline calicivirus infection: clinical signs and lesions. J Am Vet Med Assoc (1975) 1.06
Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus. Cancer Res (1977) 1.05
Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein. J Virol (1990) 1.05
Flow cytometric analysis of T-lymphocyte subsets in cats. Vet Immunol Immunopathol (1991) 1.05
Modifications of the immunofluorescence assay for feline leukemia virus group-specific antigens. Am J Vet Res (1978) 1.03
Feline leukemia virus infection: age-related variation in response of cats to experimental infection. J Natl Cancer Inst (1976) 1.03
Maternal-fetal feline immunodeficiency virus transmission: timing and tissue tropisms. J Infect Dis (1998) 1.02
Lesions produced by feline picornaviruses of different virulence in pathogen-free cats. Vet Pathol (1973) 1.02
Reactivation of latent feline leukaemia virus infection. Nature (1982) 1.00
Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections. AIDS (1997) 1.00
Structure and pathogenicity of individual variants within an immunodeficiency disease-inducing isolate of FeLV. Virology (1992) 1.00
Experimental chronic wasting disease (CWD) in the ferret. J Comp Pathol (2008) 0.99
Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses. J Virol (1993) 0.98
Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins. J Virol (1993) 0.98
Analysis of a feline immunodeficiency virus provirus reveals patterns of gene sequence conservation distinct from human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1995) 0.98
In vivo monocyte tropism of pathogenic feline immunodeficiency viruses. J Virol (1999) 0.98
Bone marrow transplantation in the feline model of arylsulfatase B deficiency. Birth Defects Orig Artic Ser (1986) 0.98
Infectivity of lion and puma lentiviruses for domestic cats. J Gen Virol (1997) 0.96
Disease progression and viral genome variants in experimental feline leukemia virus-induced immunodeficiency syndrome. J Acquir Immune Defic Syndr (1991) 0.95
Cell-specific envelope glycosylation distinguishes FIV glycoproteins produced in cytopathically and noncytopathically infected cells. Virology (1992) 0.94
Lymphocyte mitogen reactivity and enumeration of circulating B- and T-cells during feline leukemia virus infection in the cat. J Natl Cancer Inst (1976) 0.94
Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis. J Clin Microbiol (1992) 0.94
Prospective characterization of the clinicopathologic and immunologic features of an immunodeficiency syndrome affecting juvenile llamas. Vet Immunol Immunopathol (1995) 0.94
Induction of aplastic anemia by intra-bone marrow inoculation of a molecularly cloned feline retrovirus. Leuk Res (1989) 0.93
Immunization against feline oncarnavirus disease using a killed tumor cell vaccine. Cancer Res (1976) 0.92
Immunodeficiency syndrome associated with wasting and opportunistic infection in juvenile llamas: 12 cases (1988-1990). J Am Vet Med Assoc (1992) 0.92
In vitro interaction of alveolar macrophages and pneumocytes with feline respiratory viruses. Infect Immun (1978) 0.91
Infectious respiratory diseases of cats. Vet Clin North Am (1976) 0.91
Identification of a putative receptor for subgroup A feline leukemia virus on feline T cells. J Virol (1992) 0.90
FeLV-related sequences in DNA from a FeLV-free cat colony. Virology (1976) 0.89
Pathogenesis of acute toxoplasmosis in specific-pathogen-free cats. Vet Pathol (1981) 0.88
Development of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus. Am J Vet Res (1995) 0.88
Determinants of susceptibility and resistance to feline leukemia virus infection. I. Role of macrophages. J Natl Cancer Inst (1981) 0.88
Passive immunity to feline leukemia: evaluation of immunity from dams naturally infected and experimentally vaccinated. Infect Immun (1977) 0.88
Differences in acute and convalescent-phase antibodies of cats infected with feline picornaviruses. Infect Immun (1974) 0.88
Horizontal transmission of feline leukemia virus under experimental conditions. J Natl Cancer Inst (1977) 0.88
Feline immunodeficiency virus clade C mucosal transmission and disease courses. AIDS Res Hum Retroviruses (2000) 0.87
Colony forming T lymphocyte deficit in the development of feline retrovirus induced immunodeficiency syndrome. Blood (1989) 0.87
Detection of feline leukemia virus in tissues of cats by a paraffin embedding immunofluorescence procedure. J Natl Cancer Inst (1978) 0.87
Characterization of feline T-and B-lymphocytes and identification of an experimentally induced T-cell neoplasm in the cat. J Natl Cancer Inst (1976) 0.87
Active and passive immunization of cats with inactivated feline oncornaviruses. J Natl Cancer Inst (1977) 0.86
Relationship of lymphoid lesions to disease course in mucosal feline immunodeficiency virus type C infection. Vet Pathol (2000) 0.86
Experimental and naturally occurring transplacental transmission of canine distemper virus. Am J Vet Res (1977) 0.86
Relationship between feline leukemia virus antigen expression and viral infectivity in blood, bone marrow, and saliva of cats. Cancer Res (1977) 0.85
Vertical transmission of feline immunodeficiency virus. Semin Vet Med Surg (Small Anim) (1995) 0.85
Diffuse alveolar damage in cats induced by nitrogen dioxide or feline calicivirus. Am J Pathol (1977) 0.84
Bone lesions in cats with anemia induced by feline leukemia virus. J Natl Cancer Inst (1974) 0.84
FeLV-FAIDS-induced immunodeficiency syndrome in cats. Vet Immunol Immunopathol (1989) 0.84
Feline immunodeficiency virus cell entry. J Virol (2001) 0.84
In vivo cell and tissue tropism of SIVsmmPBj14-bcl.3. AIDS Res Hum Retroviruses (1999) 0.84
Early lesions in cats inoculated with feline leukemia virus. Cancer Res (1973) 0.84
Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection. AIDS Res Hum Retroviruses (2001) 0.83
Hematopoietic target cells of anemogenic subgroup C versus nonanemogenic subgroup A feline leukemia virus. J Virol (1992) 0.82
Culture and comparison of feline myeloid dendritic cells vs macrophages. J Comp Pathol (2005) 0.82
Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection. Cancer Res (1979) 0.82
Infectious feline leukaemia virus is erythrosuppressive in vitro. Leuk Res (1986) 0.82
Experimental oncornavirus vaccines in the cat. Cancer Res (1976) 0.82
Experimental feline viral rhinotracheitis in the germfree cat. Am J Pathol (1970) 0.82
Evaluation of 9-(2-phosphonylmethoxyethyl) adenine therapy for feline immunodeficiency virus using a quantitative polymerase chain reaction. Vet Immunol Immunopathol (1992) 0.82
Feline oncornavirus-associated cell membrane antigen. VI. Cytotoxic antibody in cats exposed to feline leukemia virus. J Natl Cancer Inst (1976) 0.81
Intranasal transmission of feline leukemia. J Natl Cancer Inst (1972) 0.81
Regression of feline immunodeficiency virus infection. AIDS Res Hum Retroviruses (1997) 0.80
Biologic and immunologic response of cats to experimental infection with feline leukemia virus. Bibl Haematol (1975) 0.80